Antibiotic G1549, isolated from culture broth of Pseudoumonas alcaligeues, is a new cyclic hydroxamic acid with a 1-hydroxy-2(IH)-pyridinone structure that complexes with metals. The structure of G1549 is suggested to be 1-hydroxy-5-met hoxy-6-methyl-2(1H)-pyridinone. In vitro, G1549 and its copper and ferric complexes show moderate activity against Grampositive bacteria, fungi and Triclronronas roginalis. Topical application of G1549 and its copper and ferric complexes protect guinea pigs against cutaneous infection with lMicrocporum cams. The compounds, however, have some systemic toxicity in mice. 
Experimental

Organism
The antibiotic is produced by Pseudonwonas alcaligenes°', isolated as a laboratory contaminant. It has been deposited in the National Collection of Industrial Bacteria, Aberdeen, Scotland and designated as NCIB 11492.
Fermentation
Growth of the organism from a slope of nutrient agar (Oxoid Ltd ., London, England) was suspended in 5 ml sterile distilled water and 0.5 ml of the suspension was transferred to 100 ml nutrient broth (Oxoid Ltd.) in a 250-m1 conical flask. The flask was shaken (220 rev/minute on an orbital shaker with a 2-cm travel) for 18 hours at 28°C.
A portion (40 ml) of growth liquor from the shake flask was transferred to 4 litres of medium (yeast extract, Oxoid L21, 0.9%; neutralised peptone, Oxoid L34, 0.18 %; KH2PO4, 0.1 %; MgS0.4-7H20, 0.05 %; glycerol, 2.0 %; made up in distilled water and adjusted to pH 7.0 with sodium hydroxide) in a 5-litre fermentor. The mixture was stirred (550 rev/minute) and aerated (6 litres air/minute) for 24 hours at 22°C.
A portion (1.5 litres) of growth liquor from the 5-litre fermentor was transferred to 150 litres of the same medium in a 230-litre fermentor. The mixture was stirred (50 rev/minute) and aerated (283 litres air/minute) for 68 hours at 22°C. Antifoam (polypropylene glycol) was added as required throughout the fermentation.
Antibiotic isolation Broth (135 litres) at harvest was adjusted to pH 7.0 with hydrochloric acid and centrifuged at 10 20°C for a throughput time of 45 minutes (Westfalia KO 2006 chamber bowl centrifuge, Oelde, Westfalia, Germany) to separate aqueous solution from cells. Chilled aqueous solution (125 litres) was adjusted to pH 3.0 with hydrochloric acid and extracted with 3 one-third volumes of ethyl acetate. The ethyl acetate extracts were combined and evaporated to dryness.
The residue was extracted with methanol, filtered to remove inactive solid and the filtrate was fractionated with methanol on a column of Sephadex LH2O (100 x 9 cm; Pharmacia Fine Chemicals AB., Uppsala, Sweden). Fractions active against both Staphylococcus aureus and Escherichia coli were collected in two pools well separated from each other. The first pool to elute from the column was purified as given below, the second was a mixture of metal complexes of the antibiotic present in the first pool and was not purified further.
The first pool was evaporated; the residue was extracted with acetonitrile -water (7: 3 by volume), filtered and the filtrate was fractionated with the same solvent on a column of Sephadex LH2O (150 x 4 cm). Fractions active against both test organisms were combined and evaporated to a solid.
Preparation of G1549 copper complex The solid obtained from the second Sephadex column was dissolved in the minimal volume of methanol and a solution of saturated copper sulphate in water added. Green crystalline solid (8 g), the copper complex of G1549, was collected and dried under reduced pressure.
Preparation of G1549 ligand and its ethanolamine salt Hydrogen sulphide was passed into a chloroform solution of G1549 copper complex for 30 minutes. Copper sulphide precipitate was removed by filtration (filter aid) and the filtrate was evaporated to dryness to give G1549 ligand as a brown solid.
An aqueous solution of ligand was neutralised with aqueous ethanolamine and the neutral solution freeze-dried to give the ethanolamine salt of G1549 ligand as a brown solid.
Preparation of G1549 ferric complex G1549 ligand was dissolved in the minimal volume of methanol; ferric chloride, dissolved in a small volume of distilled water, was added to the solution of ligand to give a molar ratio of ligand to FeCI3 of 10: 1. The solution was left for 24 hours at -20°C and red crystalline solid that formed was filtered and dried under reduced pressure.
Preparation of reduction product of G1549 ligand G1549 ligand (100 mg), 2 M hydrochloric acid (35 ml) and excess zinc granules were heated under reflux for 5 hours. The mixture was filtered and the filtrate (pH 1.2) neutralised with sodium hydroxide solution to pH 7. A precipitate of zinc hydroxide was removed by filtration and the clear filtrate (pH 7) was extracted three times with an equal volume of butan-l-ol. The combined butan-l-ol extracts were evaporated to dryness to yield 20 mg of white solid, the reduction product of G1549 ligand.
Thin-layer chromatography
The methods used were as described by NOBLE et al. 3) Spectroscopy Proton NMR and 13C NMR spectra were recorded on Jeol MH100 and Jeol FX100 spectrometers.
Mass spectra (electron ionisation and field desorption) were recorded on a Varian MAT 311A spectrometer.
In vitro assays
Fermentation broths and extracts: Production of antibiotic activity during growth of the organism was followed by an agar diffusion cup-plate assay. Antibiotic extracts were assayed by an agar diffusion method in which samples were applied to Whatman 3MM paper.
Test organisms were Staphylococcus aureus Oxford H strain VI and Escherichia coli 573E (Glaxo strain). Details of the methods have been given by NOBLE et al. 3' Minimum inhibitory concentration:
The minimum inhibitory concentration (MIC) of test compounds was determined against a range of Gram-positive and Gram-negative bacteria using a broth dilution method in microtitre plates" and against a range of pathogenic fungi using a tube dilution method".
Anti-trichomonas: Activity against Trichomonas vaginalis was determined by a tube dilution method using Trichomouas medium No. 2 (Oxoid Ltd.) as modified by BUSHBY and Coppg1 and SQUIRES and MCFADZEAN".
In vivo assays
Antifungal:
The activity of test compounds was assessed after their topical application to guinea pig (female, 300-S350 g Porcellus strain) skin infected with Microsporum cams (DO 3185, kindly supplied by Prof. J. C. GENTLES, Glasgow University, Scotland). An area (2.5 cm') on the flank of each animal was closely clipped and the site lightly abraded.
Alicrosporurrt cams was grown on rice medium (8 g rice to 25 ml water) and 0.2 ml of a suspension in distilled water containing 2.5 x 10' macroconidia/ml was rubbed into the abraded area of skin. The inoculated site was covered with an occlusion dressing (cling-film) secured with adhesive tape and left 2-. 3 days before removal. After 5 days, each site was treated twice daily with 0.2 ml aqueous cream (emulsifying ointment BP, 30% in distilled water) containing either 1 or 5 % (w/v) of test compound. Treatment was continued for 10 days. Infected control animals were treated similarly with cream alone.
The infection of each cutaneous site was assessed on the basis of the extent and intensity of erythema and the degree of fluorescence under ultraviolet light (340 nm).
Anti-candida: Activity of test compounds against Candida albicans C316 was determined in mice infected with either a lethal system infection or a localised abscess infection. Anti-trichomonas: Activity against Trichomonas vaginalis was determined by the method of LYNCH et a1.6' in subcutaneously infected mice. Acute mouse toxicity:
The ligand was dissolved in methanol -water (1 : 1 by volume), the copper complex was dissolved in dimethylsulphoxide -water (1: 1 by volume) and the ferric complex was suspended in saline (pH 7.0) containing 3 drops surfactant (Nonex The mass spectrum (electron ionisation, Fig. 1 ) of the ligand shows a base peak-molecular ion at m/e 155; an accurate mass measurement for this peak gave a value 155.0583, indicating a molecular formula of C;H0NO3. Table 3 .
G1549 copper complex
The copper complex is a green, crystalline Rf values of the copper complex obtained after thin-layer chromatography are given in Table 1 .
G1549 ferric complex
The ferric complex is a red solid, melting point 135-137'C; soluble in chloroform , acetone and methanol and insoluble in water.
The mass spectrum (field desorption) showed a molecular ion of m/e 518, with no other significant ions, indicating a molecular formula of (C,H,NO3)3Fe. The ultraviolet absorption spectrum of the ferric complex in methanol showed absorption maxima (nm; E;,°r" within brackets) at 224 (1216) and 318 (291). The infrared spectrum of the ferric complex Table 1 .
Biological Properties
Antibacterial spectra of 61549 ligand, the ethanolamine salt of the ligand and the copper and ferric complexes of G1549 are given in Table 4 . Antifungal and anti-Trichomonas spectra are given in Table 5 . All four compounds show moderate activity against Gram-positive bacteria, fungi and Trichomonas vaginalis.
In vivo tests showed the compounds to be inactive against systemic and cutaneous Candida albicans infections in mice and inactive against subcutaneous Trichomonas vaginalis infections in mice.
In guinea pigs infected cutaneously with Microsporutn canis topical treatment with the ligand, its ethanolamine salt and the copper complex proved as effective as 1 % tolnaftate standard (Table 6) .
It was not possible to assess the effect of the ferric complex due to the brown-red colour of the cream masking the sites of infection.
Administered i.p. to mice the LD,o of the ligand, its ethanolamine salt, copper complex and ferric complex was 250, 500, 50 and 350 mg/kg body weight respectively. Table 2 and text) obtained for G1549 ligand is consistent with either structure I or It. Eu(Fod)., shift reagent studies with the reduction product of G1549 showed a greater downfield shift of the methyl substituent compared with that of the methoxy substituent.
This suggests that the methyl group is adjacent to the ring N and thus structure I rather than It is favoured for G 1549. Also, comparison of the carbon-13 N.M.R. spectrum of 2(1H)-pyridinone with that of G1549 reduction product shows the greatest deshielding to occur at carbon d ( Table 3 ), suggesting that the methoxy group is attached to this carbon atom. This again favours structure I for G1549. Finally, the melting point of G1549 reduction product is in agreement with that quoted for 5-methoxy-6-methyl-2(IH)-pyri- G1549 belongs, therefore, to a group of cyclic hydroxamic acids produced by microorganisms that includes antibiotics and growth factors',".
Two pigment compounds, tenellin and bassianin, isolated from Beauveria species',"', contain a 1-hydroxy-2(1H)-pyridinone ring in their structure.
A series of synthetic 6-substituted, 1-hydroxy-4-methyl-2(IH)-pyridinone compounds with topical antifungal activity in vivo has been reported `1,`22) The activity of these was increased by increasing the lipophilicity of the substituting group and by application of the compounds as ethanolamine salts. In contrast, the ethanolamine salt of G1549 showed no increase in topical antifungal activity compared with G1549.
G1549 forms stable metal complexes with copper (Cu2T) and iron (Fe'"). These complexes, however, did not appear markedly to increase the biological effectiveness of G 1549 in the tests used.
